Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Diarrhea-predominant Irritable Bowel Syndrome
View Full LandscapeTarget Indication
Diarrhea-predominant Irritable Bowel Syndrome
Clinical Trial
NCT01870895Last updated: 7/10/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.